Complications of Implantation

Cardiac Electrophysiology Review

Volumn 2, Issue 3, 1998, Pages 322-323

  Kosar, Erol ^a   Nademanee, Koonlawee ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Mailbox 5R   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004203713     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009967130889     Document Type: Article

References (16)

1. Kim SG, Pathapati R, Fisher JD, Rameneni A, Nagabhairu R, Ferrick KJ, Roth JA, Ben-Zur U, Gross J, Brodman R, Furman S. Comparison of long-term outcomes of patients treated with nonthoracotomy and thoracotomy implantable defibrillators. Am J Cardiol 1996; 78:1109-1112.
2. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillation in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
3. Rosenqvist M, Beyer T, Block M, denDulk K, Minten J, Lindeman F. Adverse events with transvenous implantable cardioverter-defibrillators. A prospective multicenter study. Circulation 1998;98:663-670.
4. Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. Worldwide Jewel Investigators. JACC 1996;28(5):1278-82.
5. Gold MR, Peters RW, Johnson JW, Shorofsky SR for the World-Wide Jewel Investigators. Complications associated with pectoral implantation of cardioverter defibrillation. PACE 1997;20[Pt II]:208-211.
6. Fenelon G, Huvelle E, Brugada P for the European Ventak Mini Investigator Group. Initial clinical experience with a new small sized third-generation implantable cardioverter defibrillator: Results of a multicenter study. PACE 1997;20[Pt 1]:2967-2974.
7. Parsonnet V, Bernstein AD, Neglia D. Nonthoracotomy ICD implantation: Lessons to be learned from permanent pacemaker implantation. PACE 1995;18[Pt 1]:1597-1600.
8. Magney JE, Parsons JA, Flynn DM, Hunter DW. Pacemaker and defibrillator lead entrapment: Case studies. PACE 1995;18: 1509-1517.
9. Gallik DM, Ben-Zur UM, Gross JN, Furman S. Lead fracture in cephalic versus subclavian approach with transvenous implantable cardioverter defibrillator systems. PACE 1996;19 (7):1089-1094.
10. Lee HH. Usefulness of a peelaway sheath introducer with a splittable hemostatic valve for placement of permanent pacemaker lead. Cathet Cardiovasc Diagn 1997;40:326-327.
11. Ramza BM, Rosenthal L, Hui R, Nsah E, Savader S, Lawrence JH, Tumaselli G, Berger R, Brinkler J, Calkins H. Safety and effectiveness of placement of pacemaker and defibrillator leads in the axillary vein guided by contrast venography. Am J Cardiol 1997;80(7):892-896.
12. Parsonnet V, Bernstein AD, Omar AM, Rothbart ST, Schoenfeld R. Instantaneous lead entrapment: an unusual complication of nonthoracotomy implantation of an endocardial defibrillation lead. PACE 1995;18(11):2100-2102.
13. Iskos D, Loch K, Lurie KG, Fahy GJ, Peterson-Stejskal S, Benditt DG. Submuscular versus subcutaneous pectoral implantation of cardioverter-defibrillator: effect on high voltabe impadance and defibrillation efficacy. J Intervent Card Electrophysiol 1998;2(1):47-52.
14. Sticherling C, Klingenhelen T, Cameron D, Hohnloser SH. Worldwide clinical experience with a down-sized active can implantable cardioverter defibrillator in 162 consecutive patients. PACE 1991;14:1899-1904.
15. Lehmann MH, Saksena S. Implantable cardioverter defibrillator in cariovascular practice: Report of the Policy Conference of the North American Society of Pacing and Electrophysiology. PACE 1991;14:1899-1904.
16. Da Costa A, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A, Isaaz K, Touboul P. Antibiotic prophylaxis for permanent pacemaker implantation, A meta-analysis. Circulation 1998;97:1796-1801.